1887

n South African Medical Journal - Myasthenia gravis is a rare but treatable disease : correspondence

USD

 

Abstract

Myasthenia gravis (MG) is a rare but treatable disease. Early recognition and treatment can prevent mortality and morbidity, thereby reducing the burden of the disease. In 85 - 90% of cases, the diagnosis is made with an acetylcholine receptor antibody (AChR) radioimmunoprecipitation assay. As a diagnostic test, the assay is 99.9% specific for the presence of MG. We recently reported the incidence of AChR-positive MG in South Africa (SA) based on all the laboratory data over a 2-year period (2011 - 2012). Here, we highlight two issues emanating from that research of importance to specialist services delivery and MG management.

Loading

Article metrics loading...

/content/m_samj/105/8/EJC174001
2015-08-01
2016-12-08
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error